Home » Molecular Insight Raises $28 Million in Venture Capital
Molecular Insight Raises $28 Million in Venture Capital
April 21, 2005
Molecular Insight Pharmaceuticals Inc. said it raised $28 million in a third round of venture financing that will enable the Cambridge firm to take its cardiac-imaging compound into pivotal clinical trials. The privately held firm is developing a unique fatty acid marked with iodine that could enable doctors to better visualize reduced blood flow within the heart when patients experience chest pain. Better diagnosis of such patients in emergency rooms could help reduce the number of heart attacks and identify heart attacks that would otherwise go undetected.
The Boston Globe (http://www.boston.com/business/articles/2005/04/21/molecular_insight_raises_28m_in_venture_capital/?rss_id=Boston%2BGlobe%2B--%2BBusiness%2BNews)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct